4197X-RA immunotoxin to destroy lens epithelial cells in the eye data

HBI (The Woodlands, Texas) reported a trend toward less opacification in an interim analysis of 60 patients in a Phase I/II trial of 63 patients.

In a follow-up that so far has ranged from six weeks to a year past surgery, the lower of the two tested doses appears to be most effective. ...